Literature DB >> 12117877

Expression of CDX2 in normal and neoplastic human colon tissue and during differentiation of an in vitro model system.

D Qualtrough1, T Hinoi, E Fearon, C Paraskeva.   

Abstract

BACKGROUND: The Cdx genes are expressed in the colorectal epithelium and are frequently downregulated during tumorigenesis. Overexpression of Cdx genes has been shown previously to result in cellular differentiation. AIM: To study expression of CDX2 in normal and neoplastic human colon using a newly isolated monoclonal antibody. To define expression of CDX1 and CDX2 in an in vitro model system of colorectal tumour progression and to ascertain whether these are subject to regulation during differentiation.
METHODS: Normal and neoplastic human colon was immunostained for CDX2. CDX1 and CDX2 expression was assayed in cell lines derived from premalignant colonic adenomas by western blotting. Differentiation was induced by sodium butyrate treatment or post confluent growth, and changes in CDX expression compared with carcinoma cell lines with low levels of CDX expression.
RESULTS: CDX2 protein displayed no gradient of expression within the colonic crypt. Cell lines derived from adenomas, with high levels of CDX1 and CDX2, showed no regulation of these proteins when induced to differentiate by butyrate or confluency. CDX expression in these cell lines was independent of their APC or Ras status. CDX1 and CDX2 were expressed at very low levels in some carcinoma cell lines and were modestly upregulated on differentiation but were not restored to levels seen in adenoma cells.
CONCLUSION: The lack of significant regulation on cellular differentiation and the absence of a detectable gradient in the crypt implies that CDX2 may confer tissue specificity but may not play the previously suggested role in crypt patterning.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117877      PMCID: PMC1773308          DOI: 10.1136/gut.51.2.184

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling.

Authors:  L T da Costa; T C He; J Yu; A B Sparks; P J Morin; K Polyak; S Laken; B Vogelstein; K W Kinzler
Journal:  Oncogene       Date:  1999-09-02       Impact factor: 9.867

2.  Cdx1 promotes differentiation in a rat intestinal epithelial cell line.

Authors:  P Soubeyran; F André; J C Lissitzky; G V Mallo; V Moucadel; M Roccabianca; H Rechreche; J Marvaldi; I Dikic; J C Dagorn; J L Iovanna
Journal:  Gastroenterology       Date:  1999-12       Impact factor: 22.682

3.  An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis.

Authors:  A C Williams; T J Collard; C Paraskeva
Journal:  Oncogene       Date:  1999-05-27       Impact factor: 9.867

4.  Dome formation by a human colonic adenocarcinoma cell line (HCA-7).

Authors:  S C Kirkland
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

5.  Potentiation by specific short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines.

Authors:  B G Heerdt; M A Houston; L H Augenlicht
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

6.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

Authors:  J H Cummings; E W Pomare; W J Branch; C P Naylor; G T Macfarlane
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

7.  Specific cytogenetic abnormalities and k-ras mutation in two new human colorectal-adenoma-derived cell lines.

Authors:  A C Williams; S J Harper; C J Marshall; R W Gill; R A Mountford; C Paraskeva
Journal:  Int J Cancer       Date:  1992-11-11       Impact factor: 7.396

8.  Downregulation of the colon tumour-suppressor homeobox gene Cdx-2 by oncogenic ras.

Authors:  O Lorentz; A Cadoret; I Duluc; J Capeau; C Gespach; G Cherqui; J N Freund
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

9.  Butyrate- but not TGFbeta1-induced apoptosis of colorectal adenoma cells is associated with increased expression of the differentiation markers E-cadherin and alkaline phosphatase.

Authors:  A J Butt; A Hague; C Paraskeva
Journal:  Cell Death Differ       Date:  1997-12       Impact factor: 15.828

10.  Growth, morphology and chemosensitivity studies on postconfluent cells cultured in 'V'-bottomed microtiter plates.

Authors:  P E Pizao; D M Lyaruu; G J Peters; J van Ark-Otte; B Winograd; G Giaccone; H M Pinedo
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

View more
  17 in total

1.  Adhesion of Moraxella catarrhalis to human bronchial epithelium characterized by a novel fluorescence-based assay.

Authors:  Hortense Slevogt; Krishna N Tiwari; Bernd Schmeck; Andreas Hocke; Bastian Opitz; Norbert Suttorp; Joachim Seybold
Journal:  Med Microbiol Immunol       Date:  2005-07-30       Impact factor: 3.402

2.  CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors.

Authors:  Stefano La Rosa; Elena Rigoli; Silvia Uccella; Anna Maria Chiaravalli; Carlo Capella
Journal:  Virchows Arch       Date:  2004-07-29       Impact factor: 4.064

3.  IGFBP-rP1, a potential molecule associated with colon cancer differentiation.

Authors:  Wenjing Ruan; Shuzhen Zhu; Haibing Wang; Fangying Xu; Hong Deng; Yu Ma; Maode Lai
Journal:  Mol Cancer       Date:  2010-10-26       Impact factor: 27.401

4.  CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumours.

Authors:  Filippo Fraggetta; Giuseppe Pelosi; Alessia Cafici; Paolo Scollo; Paolo Nuciforo; Giuseppe Viale
Journal:  Virchows Arch       Date:  2003-10-24       Impact factor: 4.064

5.  Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines.

Authors:  A Buda; D Qualtrough; M A Jepson; D Martines; C Paraskeva; M Pignatelli
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

6.  Loss of CDX1 expression in colorectal carcinoma: promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines.

Authors:  N A C S Wong; M P Britton; G S Choi; T K Stanton; D C Bicknell; J L Wilding; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-02       Impact factor: 11.205

Review 7.  Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.

Authors:  Günter Klöppel; Guido Rindi; Martin Anlauf; Aurel Perren; Paul Komminoth
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

8.  Characterization of the 5'-flanking region and regulation of expression of human anion exchanger SLC26A6.

Authors:  Seema Saksena; Alka Dwivedi; Amika Singla; Ravinder K Gill; Sangeeta Tyagi; Alip Borthakur; Waddah A Alrefai; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

9.  Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence.

Authors:  Jing Xu; Bingjian Lü; Fangying Xu; Hongguang Gu; Yihu Fang; Qiong Huang; Maode Lai
Journal:  J Cancer Res Clin Oncol       Date:  2008-02-09       Impact factor: 4.553

10.  A qualitative transcriptional signature for determining the grade of colorectal adenocarcinoma.

Authors:  Hailong Zheng; Kai Song; Yelin Fu; Tianyi You; Jing Yang; Wenbing Guo; Kai Wang; Liangliang Jin; Yunyan Gu; Lishuang Qi; Wenyuan Zhao; Zheng Guo
Journal:  Cancer Gene Ther       Date:  2019-10-09       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.